Merit Medical Systems Inc
NASDAQ:MMSI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
65.53
105.33
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Merit Medical Systems Inc
Merit Medical Systems Inc
Total Equity
Merit Medical Systems Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Equity
$1.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Total Equity
$878.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Total Equity
$2.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
0%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Total Equity
$2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Equity
$3.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Equity
$1.2B
|
CAGR 3-Years
33%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Merit Medical Systems Inc
Glance View
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.
See Also
What is Merit Medical Systems Inc's Total Equity?
Total Equity
1.3B
USD
Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Total Equity amounts to 1.3B USD.
What is Merit Medical Systems Inc's Total Equity growth rate?
Total Equity CAGR 10Y
12%
Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for Merit Medical Systems Inc have been 9% over the past three years , 7% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
